Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03098615 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating the Effect of Jublia on Dermatophytomas
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT03098615 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 19 participants.
The verdict
NCT03098615, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study will examine how Jublia affects dermatophytomas, which are difficult to treat with other therapeutic options.
Interventions
- DRUG Jublia (Efinaconazole 10% Topical Solution)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03098615
The ClinicalTrials.gov registry entry for NCT03098615 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Jublia (Efinaconazole 10% Topical Solution) is the first listed.
NCT03098615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03098615 about?
NCT03098615 is a clinical study titled "Study Evaluating the Effect of Jublia on Dermatophytomas". This study will examine how Jublia affects dermatophytomas, which are difficult to treat with other therapeutic options.
What is the current status of trial NCT03098615?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2015-09. Estimated completion is 2018-07.
What interventions are being tested in trial NCT03098615?
The interventions under investigation include: Jublia (Efinaconazole 10% Topical Solution) (DRUG).
Who is sponsoring clinical trial NCT03098615?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.